Evaluation of Transforming Growth Factor- β 1 in Diagnosis of Hepatocellular Carcinoma in Egyptain HCV Patients

Assessment of Transforming Growth Factor-β1 in Egyptian Patients with Chronic Hepatitis-C Virus and Hepatocellular Carcinoma

Biochemical study of some non invasive markers in liver fibrosis patients.

Non-Invasive Markers for Liver Fibrosis in Chronic HCV Patients

SERUM MARKERS FOR ASSESSING LIVER FIBROSIS IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B AND C CO-INFECTION VERSUS CHRONIC HEPATITIS C

Serum soluble cluster of differentiation 163 (sCD163), matrix metalloproteinase 9 (MMP9) and cytokeratin 18 (CK18) levels as biomarkers for liver fibrosis in Egyptian chronic hep

Assessment of IL-10 Polymorphism and TGF beta 1 Polymorphism in Egyptian Patients with Chronic Liver Disease

Study of Fibro Q Index as a Non invasive Method to Predict Liver Fibrosis in Chronic Hepatitis C

Estimation of Serum Interleukin-18 and Hs-CRP in Chronic Hepatitis C Infected Patients at Assuit Governorate, Egypt

Albumin- Bilirubin Score as a Non-Invasive Serum Biomarker for Advanced Liver Fibrosis and Cirrhosis in Egyptian Patients with Chronic Hepatitis C Infection: A Case-Control Study